Primary central nervous system lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
==[[Primary central nervous system lymphoma causes|Causes]]== | ==[[Primary central nervous system lymphoma causes|Causes]]== | ||
==[[Primary central nervous system lymphoma differential diagnosis|Differentiating Primary | ==[[Primary central nervous system lymphoma differential diagnosis|Differentiating Primary Central Nervous System Lymphoma from other Diseases]]== | ||
==[[Primary central nervous system lymphoma epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Primary central nervous system lymphoma epidemiology and demographics|Epidemiology and Demographics]]== | ||
Revision as of 15:38, 19 February 2016
For patient information click here
|
Primary central nervous system lymphoma Microchapters |
|
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary central nervous system lymphoma On the Web |
|
American Roentgen Ray Society Images of Primary central nervous system lymphoma |
|
Directions to Hospitals Treating Primary central nervous system lymphoma |
|
Risk calculators and risk factors for Primary central nervous system lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Synonyms and keywords: Primary CNS lymphoma; Primary central nervous system lymphomas; Primary CNS lymphomas; Primary lymphoma of the brain; PCNSL; PCNSLs; Microglioma; Primary brain lymphoma; Lymphoid malignancy
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary Central Nervous System Lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies